AAKP
AAKP Renal Flash
In This Issue
AAKP News of the Month
Very Low Body Fat Linked to Increased Risk of Death
Get Your FREE Subscription to At Home with AAKP
Medicare and Medicaid Cover Flu Vaccines
Peritoneal Dialysis is Underused in Kidney Failure Patients
New Drug Shows Promise for Maintaining Catheter Function
Contribute to AAKP When You Shop Online
Quick Links
AAKP News of the
Month: Join the AAKP Survey Panel! 
 
Small Logo AAKP 
 
AAKP invites patients, family members, health care professionals and individuals with a concern for kidney disease to join its Survey Panel. The AAKP Survey Panel's purpose is to assist with the understanding of kidney disease and its impact on the day to day lives of individuals affected by reduced renal function.

The AAKP Survey Panel will ask you a few general questions and then asks your permission to contact you in the future regarding detailed topics, such as prescription costs, insurance benefits, treatment options, etc. Joining the AAKP Survey Panel is FREE and as a member your input can influence the products and services offered to kidney patients and their family members.
 
For more information, visit the AAKP Web site or call (800) 749-2257.

 

 
December 2009 
masthead
Very Low Body Fat Linked to Increased Risk of Death
Dialysis patients with low body fat are at increased risk of death - even compared to patients at the highest level of body fat percentage, according to research presented at the American Society of Nephrology's annual meeting.

"Our study indicates that body fat may be protective in dialysis patients," comments Dr. Kamyar Kalantar-Zadeh. Nephrologists have puzzled over the 'obesity paradox' in dialysis patients. Contrary to what common sense would indicate, higher body mass index is associated with greater survival in hemodialysis patients. 
Get Your FREE Subscription to At Home with AAKP
At Home Fall09Contact AAKP today to receive your FREE subscription to At Home with AAKP! At Home with AAKP is a magazine dedicated to providing information and education for individuals participating in home dialysis therapies or those interested in starting home dialysis. The publication includes information about home dialysis therapy options, patient profiles, nutrition and cooking tips, traveling while on dialysis, and much more.
 
To receive your subscription to At Home with AAKP, please contact AAKP at info@aakp.org or (800) 749-AAKP.
 
At Home with AAKP is sponsored by DaVita, Inc. and NxStage, Inc.
Medicare and Medicaid Cover Flu Vaccines
vaccine
Medicare and Medicaid cover both the seasonal and H1N1 flu vaccines. Seniors are encouraged to get their seasonal flu vaccine as soon as possible. The vaccine that protects against the 2009 H1N1 influenza virus (sometimes called swine flu) is a separate vaccine and is available now. 
 
The first available doses of this vaccine should be given to those at highest risk of infection and complications such as children, pregnant women, health care workers and younger adults with certain medical conditions.There is some evidence that people 65 and older are less likely than younger people to be infected with the 2009 H1N1 influenza virus. For more information about the seasonal and H1N1 flu vaccines, visit www.flu.gov. 
Peritoneal Dialysis is Underused in Kidney Failure Patients
More than one-third of people over 70 years old have some degree of kidney disease. In the United States the majority of older persons with severe kidney disease are on hemodialysis (HD). A new study shows the majority of patients who are eligible for peritoneal dialysis (PD) were not offered it as a choice. This is despite the fact that patients who receive PD spend less time in the hospital and it is cheaper. 

Given the choice, one-third to one-half of older patients would choose PD over HD. The major reason for this is it can be done at home, saving the patient going into the dialysis center three times a week. In most cases persons are not offered PD because the physician feels they would not be able to perform the actions necessary to operate the machine themselves. To learn more about your dialysis options, visit http://www.aakp.org/dialysis-information/
New Drug Shows Promise for Maintaining Catheter Function
A new drug, tenecteplase, is being tested for maintaining catheter function and reducing the need for hospitalization in dialysis patients with catheters. The study, called TROPICS 3, is the largest ever, randomized controlled trial assessing dysfunction in hemodialysis catheters and showed a statistically significant difference of treatment success in patients treated with tenecteplase versus a placebo. 
 
Catheter dysfunction presents a serious issue for hemodialysis patients, as well as their treatment providers. Researchers found the drug to be very safe, with no major bleeding reported. The drug is still in the trial stage and is not yet FDA approved.
Contribute to AAKP When You Shop Online
GoodShopPlease make every dollar count this holiday season. More than 1,300 stores including Amazon, Toys R Us, Best Buy, Apple, Gap and more will donate a percentage of virtually every sale to a non-profit organization when you shop using GoodShop.com
 
Just visit Goodshop.com and type 'American Association of Kidney Patients' in the window for the cause you support. You pay nothing extra - and you can even save money as GoodShop lists thousands of money-saving coupons and free shipping offers.
astellas 
 
Astellas Pharma US, Inc. is proud to sponsor this edition of AAKP Renal Flash.